Literature DB >> 22321464

Assessment of minimal hepatic encephalopathy (with emphasis on computerized psychometric tests).

Matthew R Kappus1, Jasmohan S Bajaj.   

Abstract

Minimal hepatic encephalopathy (MHE) is associated with a high risk of development of overt hepatic encephalopathy, impaired quality of life, and driving accidents. The detection of MHE requires specialized testing because it cannot, by definition, be diagnosed on standard clinical examination. Psychometric and neurophysiologic techniques are often used to test for MHE. Paper-pencil psychometric batteries and computerized tests have proved useful in diagnosing MHE and predicting its outcomes. Neurophysiologic tests also provide useful information. The diagnosis of MHE is an important issue for clinicians and patients alike. Testing strategies depend on the normative data available, patient comfort, and local expertise.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22321464      PMCID: PMC3312030          DOI: 10.1016/j.cld.2011.12.002

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  50 in total

1.  Critical flicker frequency for quantification of low-grade hepatic encephalopathy.

Authors:  Gerald Kircheis; Matthias Wettstein; Lars Timmermann; Alfons Schnitzler; Dieter Häussinger
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

2.  Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations.

Authors:  Jasmohan S Bajaj; Muhammad Hafeezullah; Raymond G Hoffmann; Kia Saeian
Journal:  Am J Gastroenterol       Date:  2007-07-19       Impact factor: 10.864

3.  Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study.

Authors:  Piero Amodio; Francesca Campagna; Stefania Olianas; Pamela Iannizzi; Daniela Mapelli; Marco Penzo; Paolo Angeli; Angelo Gatta
Journal:  J Hepatol       Date:  2008-06-02       Impact factor: 25.083

4.  Improving the inhibitory control task to detect minimal hepatic encephalopathy.

Authors:  Piero Amodio; Lorenzo Ridola; Sami Schiff; Sara Montagnese; Chiara Pasquale; Silvia Nardelli; Ilaria Pentassuglio; Maria Trezza; Chiara Marzano; Cristiana Flaiban; Paolo Angeli; Giorgia Cona; Patrizia Bisiacchi; Angelo Gatta; Oliviero Riggio
Journal:  Gastroenterology       Date:  2010-05-11       Impact factor: 22.682

5.  A simplified psychometric evaluation for the diagnosis of minimal hepatic encephalopathy.

Authors:  Oliviero Riggio; Lorenzo Ridola; Chiara Pasquale; Ilaria Pentassuglio; Silvia Nardelli; Federica Moscucci; Manuela Merli; Sara Montagnese; Piero Amodio; Carlo Merkel
Journal:  Clin Gastroenterol Hepatol       Date:  2011-03-24       Impact factor: 11.382

6.  Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests.

Authors:  P Amodio; F Del Piccolo; P Marchetti; P Angeli; R Iemmolo; L Caregaro; C Merkel; G Gerunda; A Gatta
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

7.  Inhibitory control in children with attention-deficit/hyperactivity disorder: event-related potentials identify the processing component and timing of an impaired right-frontal response-inhibition mechanism.

Authors:  S R Pliszka; M Liotti; M G Woldorff
Journal:  Biol Psychiatry       Date:  2000-08-01       Impact factor: 13.382

8.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

9.  Development of a clinical hepatic encephalopathy staging scale.

Authors:  M Ortiz; J Córdoba; E Doval; C Jacas; F Pujadas; R Esteban; J Guardia
Journal:  Aliment Pharmacol Ther       Date:  2007-09-15       Impact factor: 8.171

10.  Acquiring and inhibiting prepotent responses in schizophrenia: event-related brain potentials and functional magnetic resonance imaging.

Authors:  Judith M Ford; Max Gray; Susan L Whitfield; And U Turken; Gary Glover; William O Faustman; Daniel H Mathalon
Journal:  Arch Gen Psychiatry       Date:  2004-02
View more
  6 in total

1.  Minimal hepatic encephalopathy in children with liver cirrhosis: diffusion-weighted MR imaging and proton MR spectroscopy of the brain.

Authors:  Ahmed Abdel Khalek Abdel Razek; Ahmed Abdalla; Amany Ezzat; Ahmed Megahed; Tarek Barakat
Journal:  Neuroradiology       Date:  2014-07-25       Impact factor: 2.804

2.  Contemporary Understanding and Management of Overt and Covert Hepatic Encephalopathy.

Authors:  Meghan NeSmith; Joseph Ahn; Steven L Flamm
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-02

3.  Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES).

Authors:  Mircea Alexandru Badea; Vasile Liviu Drug; Mihaela Dranga; Otilia Gavrilescu; Gabriela Stefanescu; Iolanda Popa; Catalina Mihai; Cristina Cijevschi-Prelipcean
Journal:  Metab Brain Dis       Date:  2016-07-27       Impact factor: 3.584

4.  Psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in China.

Authors:  Su-Wen Li; Kai Wang; Yong-Qiang Yu; Hai-Bao Wang; Yuan-Hai Li; Jian-Ming Xu
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

5.  Neurobehavioral Effects of Organic Solvents Exposure Among Wood Furniture Makers in Ile-Ife, Osun State, Southwestern Nigeria.

Authors:  Patrick Ayodeji Akinyemi; Caleb Aderemi Adegbenro; Temitope Olumuyiwa Ojo; Olanrewaju Elugbaju
Journal:  J Health Pollut       Date:  2019-05-22

6.  Liver transplant candidates have impaired quality of life across health domains as assessed by computerized testing.

Authors:  Jonathan G Stine; George J Stukenborg; Jennifer Wang; Alden Adkins; Blake Niccum; Alex Zimmet; Curtis K Argo
Journal:  Ann Hepatol       Date:  2019-09-11       Impact factor: 2.400

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.